Under-Eye Filler for Hollows: When It Helps and the Risks

Do shadows under your eyes remain even after a good night's sleep, making you consider a little filler? Sometimes that makes sense: a hyaluronic acid injection can temporarily soften a real hollow at the lower-lid–cheek junction. But if darkness is caused by pigment, visible vessels, swelling or protruding fat pads, added volume may do little or make the area look heavier.

A tear trough is an anatomical feature, not a disease or necessarily a sign of age; it can be present from youth. The decision depends on what casts the shadow, what happens when you smile and whether you swell. This thin-skinned region lies close to important vessels and eye structures, so a 'quick non-surgical injection' is not necessarily simple.

What is actually beneath the lower eyelid?

The dark border may be where thin eyelid skin meets fuller cheek tissue and casts a shadow. Nearby are the orbicularis oculi muscle, retaining ligaments, fat pads, blood vessels and fluid-drainage pathways. Age can change their proportions, but inherited anatomy matters too.

A filler does not treat 'dark circles' as a single diagnosis. Hyaluronic acid binds water and adds volume where it is placed. Contour correction may reduce a hollow's shadow but cannot directly remove brown melanin pigmentation or blue tones from vessels beneath thin skin. Prominent morning swelling deserves investigation before introducing volume.

This table cannot diagnose you. Hollowing, pigmentation and swelling can occur together. The clinician should examine you sitting up as well as reclining, at rest and smiling, because shadows change with position and expression. Filtered, flashed photographs or a raised chin are poor guides to filler suitability.

Who may benefit, and who should avoid added volume?

The more favourable case is a moderate true hollow with healthy skin, little swelling and a realistic aim: soften the transition, not erase every dark circle. Sometimes the main volume loss is in the cheeks, or midface. Assessing cheek support may change the plan or make a direct under-eye injection unnecessary.

Very thin skin, marked laxity, prominent bags, morning swelling, existing malar oedema (puffiness over the upper cheekbone) and previous eye-area procedures demand caution. Hyaluronic acid attracts water, and local lymphatic drainage is sensitive to extra volume. Even a technically careful injection can produce persistent puffiness when the anatomy is unfavourable.

Repeated marked morning swelling should not automatically be treated as cosmetic. Depending on symptoms, assessment for allergies, skin conditions or other causes may be needed. Sudden one-sided swelling, pain, redness or a visual disturbance needs medical assessment, not an appointment for an 'eye refresh'.

Tell the clinician about infection or skin inflammation at the site, serious allergies (including to lidocaine if the chosen product contains it), clotting problems and medicines that increase bleeding or bruising. Do not discontinue prescribed anticoagulants or other medication yourself. Elective filler is generally best postponed in pregnancy or breastfeeding because good safety data are lacking. If you have chronic illness, involve a clinician familiar with your history.

Can the result look natural?

With careful selection, a subtle result is possible: the shadow softens and your expressions still look like you. But this is not guaranteed. Filling every groove flat can create a bulge visible when smiling or in side lighting. Under the eyes, restraint matters: a modest result can be reviewed later; overcorrection may be difficult to fix.

Superficially placed gel can cause blue-grey discolouration (the Tyndall effect), visible edges, asymmetry, migration or fluid retention. 'Dissolvable HA filler' does not mean an instant, consequence-free undo button. Hyaluronidase is an enzyme used to break down HA filler; its use requires clinical judgment, may take several stages and may not restore the exact previous appearance.

Before relying on before-and-after images, compare matching light, camera angle, head position, expression and a genuinely late photo after swelling resolves. First-day results are not stable. Someone else's beautiful photo with very different skin thickness cannot predict yours.

Which products and regulatory indications matter?

Temporary hyaluronic acid fillers are commonly discussed under the eyes, but formulations and approved indications differ. In the United States, the FDA extended the specific indications of Juvéderm Volbella XC to infraorbital hollowing in adults over 21 in 2021, and Restylane Eyelight for that area in adults over 21 in 2023. Those are US regulatory facts about those exact products—not evidence of Armenian approval, supply or indications.

Do not assume that every 'certified filler' is suitable for the tear trough. Ask for its exact trade name, maker, local product documentation and indication, provenance and follow-up plan. A marketing term such as 'soft' or a viscosity figure cannot replace attention to swelling properties, your tissues and the clinician's competence with complications.

Permanent or unknown materials are especially difficult to manage if the outcome is unwanted. Decline products without traceable labels or treatment where no one can explain vascular-emergency response and rapid ophthalmic referral. 'Needle-free' pressure devices are not a safe shortcut around medical injection risks.

What does the procedure feel like?

The assessment includes allergies, earlier surgery, medicines and previous injections. After cleansing, local anaesthesia may be used; some specified products already contain lidocaine. Expect brief pressure, a prick or later tenderness. The injector should be a qualified clinician skilled in periorbital vascular anatomy and recognizing complications, not only achieving symmetry.

Ask whether a conservative starting volume and reassessment after swelling are planned. Another person's 'one syringe was enough' is no prescription for your anatomy. Neither a needle nor a blunt-ended cannula eliminates vascular-injury risk; instrument choice does not replace expertise.

Severe unexpected pain, sudden pallor or a vision change during injection must trigger an immediate stop and emergency response. Do not accept 'this always happens' as a reason to continue.

What will be visible afterwards, and when can I see people?

Mild swelling, tenderness, puncture spots and bruising are common. The next day's shadow may differ from the in-clinic appearance, especially with puffiness. The FDA notes that many early reactions settle over days or weeks, although some adverse events appear much later. No one can guarantee a photo-ready result in two days.

Obtain written guidance on makeup, strenuous exercise, saunas and massage around the eyes: recommendations depend on the product, injection sites and condition of the skin. Do not massage an unexpected lump based on social-media advice. Multiple punctures or a tendency to bruise may prolong visible recovery.

Which complications must never be missed?

Beyond bruises and swelling, there may be asymmetry, visible gel, bluish colour, nodules, inflammation, infection or prolonged malar oedema. A particularly serious hazard is unintended entry into or blockage of a blood vessel. Rarely, this can cause skin necrosis, vision loss including blindness, or stroke. Having hyaluronidase available does not guarantee restoration of sight after a vascular event.

Sudden vision loss or changes, eye pain, unusually severe pain, white or grey-blue skin or sudden weakness or numbness on one side of the body or difficulty speaking (possible stroke signs) require immediate emergency medical care. Do not wait for a messenger reply or the next day. Worsening redness, a hot tender swelling, discharge or fever requires urgent review for possible infection. Persistent swelling without emergency signs also needs assessment; the response depends on its cause.

Before agreeing, ask how the clinician detects vascular occlusion, what immediate emergency protocol is in place and how urgent access to an ophthalmologist or emergency service is arranged. That matters more than a promise of 'no complications here'.

How long can it last, and what if you dislike the result?

Longevity depends on the product, anatomy, tissue and individual factors. In specific US studies of Volbella XC and Restylane Eyelight, the FDA describes effects that may last up to 12 months; this is not a personal guarantee or a universal limit for other fillers. Residual material or related changes can persist longer in practice, so previous injections should be assessed before repeating treatment.

If the correction looks excessive, get examined rather than rushing to add more filler. Early visible contour may change when swelling settles. Other cases call for observation, assessment of complications or dissolving an HA filler. Find out exactly what was injected before: dissolving an HA product is not a universal fix for permanent or non-HA materials.

You can decline the first injection or a suggested extra 'for symmetry'. If there is little real hollow and you mainly want to hide fatigue, more volume will often fail to deliver the change you have in mind.

Alternatives when the shadow has another cause

With pigmentation or inflamed skin, discuss dermatological care and sun protection. For dryness and fine lines, gentle skincare or skin-quality approaches may help, but they do not replace lost deep volume. For prominent fat bags or excess skin, an oculoplastic or plastic surgeon can assess eyelid anatomy and whether blepharoplasty is appropriate; surgery has its own risks and recovery. Sometimes no injection is the best option.

If the cheeks lack support, they may be assessed independently, but this is not an obligatory multi-area treatment package. Consultation should find the least risky way to meet your actual aim. A separate guide to comparing before-and-after under-eye filler photos may help you assess images, not replace a personal examination. (Read the related guide)

Questions to ask before consenting

• Are my circles caused by hollowing, pigment, blood vessels, a fat bag or morning swelling, and what cannot filler change?
• In which positions and facial expressions was swelling risk assessed; should the cheeks be examined?
• What is the exact product, its locally authorised indication and the available patient information?
• Who will provide follow-up and assess late swelling or visible gel?
• What is the plan for vascular blockage, sight changes or infection, and where can I get immediate care?
• Could I postpone, observe, try skincare or consult another clinician?

A good outcome need not remove every shadow; it should be proportionate and avoid unnecessary volume, with risks understood. Being able to leave a consultation without an injection is part of sound decision-making.

Other questions

Can only one side be treated if hollows are uneven?

Asymmetry may be anatomical or influenced by light and fluid. One-sided correction can be considered, but both sides need evaluation at rest and in motion; matching syringe volumes mechanically may be wrong.

Can filler worsen dark circles much later?

Yes. Contour changes, inflammation or water retention may arise well after the early weeks. Do not automatically attribute later changes to age or poor sleep; identify the product and seek assessment.

Will hyaluronidase always dissolve everything?

No. Hyaluronidase acts on hyaluronic acid, not every injectable material. Its effect, possible repeat treatment and risks require clinical judgment, and the final tissue appearance may differ from before filler.

Sources

• FDA — Dermal Fillers: Uses and Risks
• FDA — Juvéderm Volbella XC: infraorbital hollow indication
• FDA — Restylane Eyelight: infraorbital hollow indication
• Liu et al. — tear-trough HA filler systematic review and meta-analysis (2024; online 2023)
• Infraorbital Hollow Rejuvenation: considerations and complications
• Optimizing Infraorbital Hollows Treatment, 2025
• Multidisciplinary consensus (2026) — filler-associated vision loss